Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1089 of 5804
-
New scan could spot childhood cancer faster
Diagnosis Not yet recruitingThe goals of the NEUROBLASTOTEP trial is to compare the diagnostics performance of a the 18F-metafluorobenzylguanidine (18F-MFBG) Positron Emission Tomography / Computed Tomography scan (PET/CT) compared to 123I-metaiodobenzylguanidine (123I-MIBG scintigraphy (current gold standa…
Phase: PHASE2 • Sponsor: Institut Curie • Aim: Diagnosis
Last updated Jun 26, 2026 13:16 UTC
-
Could pond scum help teens see better? new trial tests alga extract for rare eye disease
Disease control Not yet recruitingThe aim of this study is to determine whether 9-cis-beta Caroten rich D. Brdawiil extract is effective in the treatment of retinitis pigmentosa in adolescent patients.
Phase: PHASE1, PHASE2 • Sponsor: Sheba Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Brain stimulation gets personal: new hope for chronic pain sufferers
Symptom relief Recruiting nowPrevious research has demonstrated that repetitive magnetic brain stimulation can be an effective adjunctive treatment for several conditions, including chronic pain. However, current stimulation protocols are typically standardized and do not account for individual variability i…
Phase: NA • Sponsor: Aalborg University • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
New blood processing method could cut transfusion needs for sickle cell patients
Disease control Not yet recruitingThe overall objective of this study is to evaluate the effectiveness and safety of transfusing hypoxic red blood cells manufactured with the Hemanext ONE system in patients with sickle cell anemia. The Hemanext ONE device was cleared through the De Novo process in September 2023.
Phase: NA • Sponsor: Hemanext • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Brain training offers hope for epilepsy patients who Don't respond to drugs
Disease control Not yet recruitingA large proportion of patients (approximately 30%) with drug-resistant epilepsy are not eligible for surgical treatment. The alternatives that can be offered to reduce the frequency of seizures are neuromodulation (vagus nerve stimulation (VNS), deep brain stimulation (DBS), or t…
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New study aims to fix heart risk calculators that fail women
Knowledge-focused Not yet recruitingThis retrospective observational study, part of the EU-funded CARAMEL project, aims to develop and validate personalized cardiovascular disease (CVD) risk assessment models specifically designed for menopausal and perimenopausal women (ages 40-60). The study leverages Real World …
Sponsor: Hospital Universitario Virgen Macarena • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
New ultrasound could catch prostate cancers MRI misses
Diagnosis Not yet recruitingActive surveillance is a common approach for men with low-risk or favorable intermediate-risk prostate cancer, aimed at avoiding or delaying treatment while closely monitoring the disease. Multiparametric MRI (mpMRI) is widely used to guide diagnosis and follow-up, but it can mis…
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Diagnosis
Last updated Jun 27, 2026 09:01 UTC
-
New pain relief hope for lung cancer patients: nerve block via port
Symptom relief Not yet recruitingCancer-related pain is a common and challenging problem in patients with lung cancer, often requiring long-term pain management. Conventional pain treatments, including systemic medications, may not provide adequate relief or may cause significant side effects. The erector spina…
Phase: NA • Sponsor: Hanoi Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
New incision technique may ease Crohn's bowel blockages
Symptom relief Not yet recruitingThis study is designed as a controlled trial to evaluate the efficacy of balloon-assisted enteroscopy-guided radial incision therapy for the treatment of stricturing small bowel Crohn's disease. The study aims to compare therapeutic outcomes, procedure-related complications, and …
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
New combo targets genetic weakness in advanced cancers
Disease control Not yet recruitingThe goal of this clinical trial is to learn if the combination of lenvatinib and a PD-1 inhibitor (a type of immunotherapy) works to treat advanced solid tumors that have a specific genetic change called "11q13 amplification". It will also learn about the safety of this combinati…
Phase: PHASE2 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Could a Two-Drug combo tame Crohn's in kids?
Disease control Not yet recruitingThe goal of this clinical trial is to investigate whether there are significant differences in the efficacy of infliximab monotherapy and combined azathioprine therapy in treating pediatric Crohn's disease, as well as whether there are differences in the safety of these two treat…
Phase: NA • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Stomach drug may tame blood sugar swings in type 1 diabetes
Disease control Not yet recruitingPatients living with type 1 diabetes (PwT1D) still have trouble controlling their blood sugar, even with the latest treatments. PwT1D may have slow stomach emptying influencing blood glucose level. Treating this is an important goal. A recent study found that 30% of PwT1D had a s…
Phase: PHASE3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New hope for deadly brain cancer? early trial launches
Disease control Not yet recruitingAn Open Label, Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of FZ-AD005 in Patients with HGG, especially in DMG and other Recurrent HGG.
Phase: PHASE1 • Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New score could help stroke survivors get the right blood pressure pills faster
Disease control Recruiting nowIntracerebral hemorrhage (ICH) is the second most common form of stroke, with an incidence of around 3000 cases per year in Hong Kong. Although it only accounts for around 20-30% of all strokes, ICH is the most severe form of stroke, contributing to 50% of all stroke mortality an…
Phase: NA • Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New procedure aims to silence pelvic pain for good
Symptom relief Not yet recruitingTranscatheter Embolization of Ovarian Vein and Pelvic Venous Reservoir for Treatment of Pelvic Congestion Syndrome Secondary to May-Thurner Syndrome. This study aims to prospectively evaluate the short-term clinical outcomes and the incidence of post-embolization stenting for re…
Phase: NA • Sponsor: Mark Magdy Zekry • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
New Stent-Graft for aortic aneurysm tested in Real-World registry
Disease control Recruiting nowObjective To pragmatically collect and analyze patient-level clinical, procedural, and outcome data from participating centers in Italy and Poland on the use of the PERCUTEK Tycheseal™ stent-graft system for the endovascular repair of abdominal aortic aneurysms. The study aims to…
Sponsor: American Heart of Poland • Aim: Disease control
Last updated Jun 27, 2026 11:04 UTC
-
Can pressurized oxygen calm the storm of PTSD?
Symptom relief Recruiting nowPost-traumatic stress disorder (PTSD), affecting approximately 6% of the general population and up to one-third of individuals exposed to combat zones and disasters, is a significant contributor to morbidity and mortality among IDF personnel. Hyperbaric oxygen therapy (HBOT), in …
Phase: NA • Sponsor: Medical Corps, Israel Defense Force • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
New drug NTB003 aims to reduce bulging eyes in thyroid disease
Disease control Not yet recruitingMulticentre, Phase Ib/II Clinical Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of NTB003 in Participants with Thyroid Eye Disease
Phase: PHASE1, PHASE2 • Sponsor: Nanjing Chia-tai Tianqing Pharmaceutical • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Can a calming drug tame the deadly stress of sepsis?
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether early administration of dexmedetomidine can improve autonomic nervous system regulation and clinical outcomes in adult patients with septic shock. It will also evaluate the safety of dexmedetomidine in this population. The main…
Phase: PHASE4 • Sponsor: Sichuan Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Can a statewide program boost lung cancer screening and save lives?
Knowledge-focused Recruiting nowThis clinical trial studies whether a Quality Implementation of Lung Cancer Screening (QUILS™) System state-based initiative (SBI) intervention works to improve the statewide capacity for implementing and sustaining lung cancer screening in Mississippi (MS) and Nevada (NV). The Q…
Phase: NA • Sponsor: Timothy Mullett • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC